CL2019000951A1 - Producción de partículas re-188/186 - Google Patents
Producción de partículas re-188/186Info
- Publication number
- CL2019000951A1 CL2019000951A1 CL2019000951A CL2019000951A CL2019000951A1 CL 2019000951 A1 CL2019000951 A1 CL 2019000951A1 CL 2019000951 A CL2019000951 A CL 2019000951A CL 2019000951 A CL2019000951 A CL 2019000951A CL 2019000951 A1 CL2019000951 A1 CL 2019000951A1
- Authority
- CL
- Chile
- Prior art keywords
- particles
- activated
- particle production
- isotopes
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
- A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1028—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy using radiation sources applied onto the body
- A61N5/1029—Radioactive dressings
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21H—OBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION
- G21H1/00—Arrangements for obtaining electrical energy from radioactive sources, e.g. from radioactive isotopes, nuclear or atomic batteries
- G21H1/06—Cells wherein radiation is applied to the junction of different semiconductor materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- High Energy & Nuclear Physics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Se proporciona un proceso para producir partículas activadas que comprenden isótopos de 188Re y/o isótopos de 186 Re mediante la irradiación con neutrones de partículas de partida no volátiles e insolubles en agua que comprenden un compuesto de renio. Además, se proporciona un proceso para producir las correspondientes partículas de partida no volátiles e insolubles en agua. Además, se proporcionan las respectivas partículas de partida y partículas activadas, respectivamente, y una composición que comprende una pluralidad de partículas activadas. Las partículas activadas y la composición que las comprende son adecuadas para su uso en la terapia con radionúclidos y para aplicaciones cosméticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016119239.2A DE102016119239A1 (de) | 2016-10-10 | 2016-10-10 | Partikel und Zusammensetzung, die Rheniumverbindungen umfassen, und Prozesse zum Erhalten solcher Produkte |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019000951A1 true CL2019000951A1 (es) | 2019-09-27 |
Family
ID=60164670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019000951A CL2019000951A1 (es) | 2016-10-10 | 2019-04-09 | Producción de partículas re-188/186 |
Country Status (15)
Country | Link |
---|---|
US (1) | US11135323B2 (es) |
EP (1) | EP3523811B1 (es) |
KR (1) | KR102488513B1 (es) |
CN (1) | CN110168669B (es) |
AU (1) | AU2017343616B2 (es) |
BR (1) | BR112019007308A2 (es) |
CA (1) | CA3039834A1 (es) |
CL (1) | CL2019000951A1 (es) |
CO (1) | CO2019004738A2 (es) |
DE (1) | DE102016119239A1 (es) |
IL (1) | IL265932B (es) |
NZ (1) | NZ752287A (es) |
PL (1) | PL3523811T3 (es) |
RU (1) | RU2749141C2 (es) |
WO (1) | WO2018069329A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3854757A1 (en) | 2020-01-23 | 2021-07-28 | Technische Universität München | Rhenium sulfide particles and microwave assisted process for their preparation |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2972531A (en) * | 1958-04-18 | 1961-02-21 | Kennecott Copper Corp | Process for production of ultra-high purity rhenium |
US3260658A (en) * | 1962-10-31 | 1966-07-12 | Philip E Churchward | Process for the recovery of rhenium |
US3870779A (en) * | 1973-10-10 | 1975-03-11 | Kennecott Copper Corp | Process of recovering rhenium values from complex industrial solutions |
CA2214089A1 (en) * | 1996-08-26 | 1998-02-26 | Wei Jia | Production of 186re, 188re and other radionuclides via inorganic szilard-chalmers process |
US5862193A (en) * | 1997-08-20 | 1999-01-19 | The Curators Of The University Of Missouri | Production of 186 Re, 188 Re and other radionuclides via inorganic szilard-chalmers process |
US5796897A (en) | 1997-02-06 | 1998-08-18 | Wave Optics, Inc. | Universal adaptor for keyed fiberoptic connectors |
WO2000006243A2 (en) * | 1998-07-28 | 2000-02-10 | Innerdyne, Inc. | Absorbable brachytherapy and chemotherapy delivery devices and methods |
CN1075389C (zh) * | 1999-05-14 | 2001-11-28 | 中国科学院上海原子核研究所 | 铼核素标记碘化油溶胶制剂、制备方法及其应用 |
RU2159296C1 (ru) * | 1999-06-10 | 2000-11-20 | Институт минералогии, геохимии и кристаллохимии редких элементов | Способ извлечения рения и других металлов |
RU2222626C1 (ru) * | 2002-05-07 | 2004-01-27 | Государственное унитарное предприятие "Всероссийский научно-исследовательский институт химической технологии" | Способ извлечения рения и других элементов |
US20040197264A1 (en) * | 2003-04-04 | 2004-10-07 | Alexander Schwarz | Microspheres comprising therapeutic and diagnostic radioactive isotopes |
WO2005018681A1 (en) * | 2003-06-03 | 2005-03-03 | The Trustees Of The University Of Pennsylvania | Nanoradiopharmaceuticals and methods of use |
EP2142284A4 (en) | 2007-03-31 | 2015-12-23 | Advanced Applied Physics Solutions Inc | METHOD AND DEVICE FOR INSULATING 186RHENIUM |
US8821364B2 (en) * | 2008-09-02 | 2014-09-02 | Battelle Memorial Institute | Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
CN102671219B (zh) * | 2011-03-11 | 2013-12-11 | 成都云克药业有限责任公司 | 一种放射性阴离子树脂微球及其制备方法 |
DE102011050848B4 (de) * | 2011-06-06 | 2015-10-01 | ITM Isotopen Technologien München AG | Schichtaufbau zur epidermalen Radionuklidtherapie |
RU2481660C1 (ru) * | 2011-12-29 | 2013-05-10 | Федеральное государственное унитарное предприятие "Государственный научный центр Российской Федерации - Физико-энергетический институт имени А.И. Лейпунского" | Способ получения генераторного радионуклида рений-188 |
TWI538690B (zh) * | 2011-12-30 | 2016-06-21 | 行政院原子能委員會核能研究所 | 一種製備錸-188或錸-186人類血清白蛋白微球體之方法及套件與該套件之使用方法 |
RU2476942C1 (ru) * | 2012-01-10 | 2013-02-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" | Способ получения радионуклида рений-188 без носителя и устройство для его осуществления |
WO2014159759A1 (en) * | 2013-03-13 | 2014-10-02 | Biosphere Medical, Inc. | Compositions and associated methods for radioisotope-binding microparticles |
CN105288743B (zh) * | 2014-07-23 | 2018-08-21 | 上海交通大学医学院附属第九人民医院 | 放射性核素标记的介孔生物玻璃纳米颗粒及其制备方法与应用 |
RU2621516C1 (ru) | 2016-02-25 | 2017-06-06 | Общество с ограниченной ответственностью "Институт вулканологии и геодинамики" | Способ извлечения рения и других элементов |
-
2016
- 2016-10-10 DE DE102016119239.2A patent/DE102016119239A1/de not_active Withdrawn
-
2017
- 2017-10-10 EP EP17788168.7A patent/EP3523811B1/en active Active
- 2017-10-10 BR BR112019007308A patent/BR112019007308A2/pt unknown
- 2017-10-10 AU AU2017343616A patent/AU2017343616B2/en active Active
- 2017-10-10 PL PL17788168T patent/PL3523811T3/pl unknown
- 2017-10-10 CN CN201780062421.9A patent/CN110168669B/zh active Active
- 2017-10-10 US US16/340,450 patent/US11135323B2/en active Active
- 2017-10-10 RU RU2019113502A patent/RU2749141C2/ru active
- 2017-10-10 KR KR1020197013393A patent/KR102488513B1/ko active IP Right Grant
- 2017-10-10 WO PCT/EP2017/075826 patent/WO2018069329A1/en unknown
- 2017-10-10 NZ NZ752287A patent/NZ752287A/en unknown
- 2017-10-10 CA CA3039834A patent/CA3039834A1/en active Pending
-
2019
- 2019-04-09 IL IL265932A patent/IL265932B/en unknown
- 2019-04-09 CL CL2019000951A patent/CL2019000951A1/es unknown
- 2019-05-08 CO CONC2019/0004738A patent/CO2019004738A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2017343616A1 (en) | 2019-05-16 |
CN110168669A (zh) | 2019-08-23 |
RU2749141C2 (ru) | 2021-06-07 |
PL3523811T3 (pl) | 2021-10-11 |
CN110168669B (zh) | 2023-10-27 |
BR112019007308A2 (pt) | 2019-07-02 |
AU2017343616B2 (en) | 2022-07-21 |
IL265932B (en) | 2022-04-01 |
CO2019004738A2 (es) | 2019-05-21 |
US20190290789A1 (en) | 2019-09-26 |
US11135323B2 (en) | 2021-10-05 |
DE102016119239A1 (de) | 2018-04-12 |
IL265932A (en) | 2019-05-30 |
EP3523811A1 (en) | 2019-08-14 |
NZ752287A (en) | 2023-07-28 |
EP3523811B1 (en) | 2021-04-14 |
RU2019113502A3 (es) | 2020-11-13 |
KR102488513B1 (ko) | 2023-01-12 |
RU2019113502A (ru) | 2020-11-13 |
KR20190058645A (ko) | 2019-05-29 |
CA3039834A1 (en) | 2018-04-19 |
WO2018069329A1 (en) | 2018-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019006485A2 (es) | Anticuerpos y metodos de su utilizacion | |
UY37703A (es) | Compuestos heteroarílicos bicíclicos 6-6 fusionados y su uso como inhibidores de lats | |
CO2017005650A2 (es) | Anticuerpos anti-interleucina-33 | |
EA201792613A1 (ru) | Модуляторы cot и способы их применения | |
BR112017012679A2 (pt) | compostos imunomoduladores, seus usos, composição e kit | |
BR112018003186A2 (pt) | anticorpos anti-pd-1 e seus métodos de uso | |
MX2021008976A (es) | Inhibidores marcados de antigeno prostatico especifico de membrama (psma), su uso como agentes formadores de imagenes y agentes farmaceuticos para el tratamiento de cancer de prostata. | |
CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
SA518391121B1 (ar) | 18f مثبطات موسومة بواسطة (psma) في مستضد الغشاء الخاص بالبروستاتا واستخدامها كعوامل تصوير تشخيصي لحالات سرطان البروستاتا | |
BR112015025025A2 (pt) | composições terapêuticas e usos das mesmas | |
CR20150314A (es) | Pirimido-[4,5-b]-quinolina-4,5 (3h, 10h)-dionas como supresoras de mutación sin sentido | |
BR112017027887A2 (pt) | partículas e suspensões radioterapêuticas | |
ECSP16096831A (es) | Derivados de naftiridinadiona | |
ECSP17013904A (es) | Angiopoietin-like 4 antibodies and methods of use | |
CL2020001137A1 (es) | Anticuerpos anti-apoc3 y métodos de uso de estos. | |
CO2019002361A2 (es) | 1–arilnaftiridin–3–carboxamidas 7–sustituidas y su uso | |
CL2019000951A1 (es) | Producción de partículas re-188/186 | |
CL2020001675A1 (es) | Péptidos asociados a tumor y su uso en la inmunoterapia contra el cáncer (divisional solicitud 201702346) | |
BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso | |
MY182398A (en) | Cosmetic product comprising water-insoluble sponge impregnated with cosmetic composition having ultraviolet ray blocking function | |
WO2019016597A3 (en) | SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES | |
BR112016012002A2 (pt) | Vitanolídeos úteis para o tratamento de doenças neurodegenerativas | |
UY37064A (es) | Método de purificación | |
UY37065A (es) | Método de purificación | |
CO2021015462A2 (es) | Anticuerpos y formulaciones de anti-cd38 |